Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.490
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
1.520
+0.030 (2.01%)
After-hours: Feb 21, 2025, 5:56 PM EST
Iterum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 52 | 49 | 26 | 10 | 72 | 49 | |
| Market Cap Growth | 84.01% | 84.01% | 157.57% | -85.65% | 47.53% | -27.45% | |
| Enterprise Value | 73 | 57 | 11 | -22 | 16 | 86 | |
| Last Close Price | 1.49 | 1.77 | 1.97 | 0.84 | 5.88 | 14.83 | |
| PB Ratio | -12.63 | -11.93 | -4.13 | 0.37 | 1.43 | -0.96 | |
| P/TBV Ratio | - | - | - | 0.39 | 1.53 | - | |
| Debt / Equity Ratio | -11.17 | -11.17 | -3.05 | 1.08 | 0.61 | -0.95 | |
| Quick Ratio | 1.37 | 1.37 | 1.79 | 6.75 | 6.38 | 0.49 | |
| Current Ratio | 1.41 | 1.41 | 1.89 | 6.89 | 6.43 | 0.51 | |
| Return on Equity (ROE) | - | - | -355.35% | -113.59% | - | - | |
| Return on Assets (ROA) | -32.98% | -32.98% | -63.74% | -23.99% | -24.67% | -68.59% | |
| Return on Capital (ROIC) | -42.78% | -42.78% | -83.33% | -27.37% | -39.23% | - | |
| Earnings Yield | -48.08% | -50.87% | -144.97% | -432.40% | -127.86% | -107.14% | |
| FCF Yield | -51.96% | -54.97% | -148.65% | -180.37% | -22.21% | -112.36% | |
| Buyback Yield / Dilution | -51.97% | -51.97% | -5.93% | -12.35% | -580.42% | -65.38% | |
| Total Shareholder Return | -51.97% | -51.97% | -5.93% | -12.35% | -580.42% | -65.38% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.